VERO (Venus Concept Corporation) Total Debt to Capital

Public company logo of Venus Concept Corp (VERO)

Venus Concept Inc. (VERO) aims for dominance in the non-invasive cosmetology sector by expanding its range of RF and laser systems through a subscription model. The stock price trend reflects a total debt-to-equity ratio of 0.00. Stability is provided by manufacturing plants in the Dominican Republic and Israel, which optimize supply chains. Low political risks and the humanitarian status of the products ensure the uninterrupted operation of global trade networks.

VERO: Venus Concept Debt to Capital 07/04/2022 - 02/21/2026
Finished products of Venus Concept Inc.

Scaling the clinic network and leasing Venus Concept Inc. (VERO) systems require significant capital expenditures; therefore, the total liabilities-to-equity ratio is critical for assessing the sustainability of the business model. This indicator measures the proportion of borrowed funds relative to equity, allowing investors to determine the degree of financial leverage and the risk of bankruptcy should demand for consumables decline.

Competitors of Venus Concept Inc.

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio iridex.com IRIX|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Total Debt to Capital Beyond Air Inc XAIR|PFSA - Debt to Equity|SSKN: Debt to Equity|GCTK (GlucoTrack) - Total Debt to Equity Ratio|NanoVibronix Inc. - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.